MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.acvd.2025.10.333

Медицинская библиотека · Archives of cardiovascular diseases · 2026

Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy.

Algalarrondo Vincent, Lairez Olivier, Narbeburu Marion, Fournier Pauline, Costa Jerome, Pelcot Francoise, Farrugia Agnes, Durand-Zaleski Isabelle, Lilliu Herve, Bartoli Mathilde, Fievez Stephane, Rudant Jeremie, Coste Agathe, Noirot Cosson Charlotte, Squara Pierre Alexandre, Canali Giorgia, de Neuville Bertrand, Slama Michel S, Charron Philippe, Damy Thibaud

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Transthyretin amyloidosis can lead to transthyretin amyloid cardiomyopathy (ATTR-CM) and heart failure.

AIMS: To describe the prevalence of cardiac and extracardiac diseases in patients with ATTR-CM and examine mortality predictors, including diuretic dosage, using the French National Health Database.

METHODS

Patients with ATTR-CM and their medical characteristics were identified from the French database from 2011 to 2019. Diuretic doses were categorized into four classes (furosemide dose: level 1<20mg; level 2 20 to <60mg; level 3 60 to<120mg; level 4 ≥120mg). Predictive factors for mortality were examined.

RESULTS

Of 7804 patients with ATTR-CM, 33.0% were on level 1 diuretics, 25.8% on level 2, 15.8% on level 3 and 25.3% on level 4 at diagnosis. Leading extracardiac conditions included kidney disease (37.0%), diabetes (29.5%), neurologic disorders (17.9%), gastrointestinal disorders (15.7%) and musculoskeletal conditions (11.8%). Median (95% confidence interval [CI]) survival was 3.1 (3.0-3.3) years. Multivariable analysis identified age at diagnosis (hazard ratio [HR] 1.482, 95% CI 1.400-1.558), male sex (HR 1.258, 95% CI 1.125-1.406), diuretic dose (HR 1.380, 95% CI 1.315-1.449), heart failure (HR 1.251, 95% CI 1.090-1.437), arrhythmia/conduction disorder (HR 1.143, 95% CI 1.001-1.306), kidney disease (HR 1.224, 95% CI 1.104-1.358), gastrointestinal disorder (HR 1.143, 95% CI 1.000-1.307) and diabetes (HR 1.192, 95% CI 1.071-1.326) as significantly associated with mortality.

CONCLUSION

Patients with ATTR-CM face a significant burden of associated diseases requiring comprehensive management alongside their ATTR-CM treatment. Beyond addressing these comorbidities, diuretic dosage emerges as a pivotal prognostic indicator.

Для цитирования: Algalarrondo Vincent, Lairez Olivier, Narbeburu Marion, Fournier Pauline, Costa Jerome, Pelcot Francoise, Farrugia Agnes, Durand-Zaleski Isabelle, Lilliu Herve, Bartoli Mathilde, Fievez Stephane, Rudant Jeremie, Coste Agathe, Noirot Cosson Charlotte, Squara Pierre Alexandre, Canali Giorgia, de Neuville Bertrand, Slama Michel S, Charron Philippe, Damy Thibaud. Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy.. Archives of cardiovascular diseases. 2026. DOI: 10.1016/j.acvd.2025.10.333.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.